Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Filing Action Memo, April 20, 2009 - Laviv

Date: 20 April 2009
To: BLA Committee             
From: Lori A. Tull, RAC       
Subject: STN 125348/0 Filing Action        
I have reviewed the Clinical Study Report (Module 5) section(s) of Isolagen Technologies Incorporated’s BLA (STN Number 125348/0) and find the application acceptable for filing.
 (Signature of Committee Member)
(Supervisory Concurrence)

Page Last Updated: 02/21/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English